February 5, 2008 - Mitralign Inc. said it successfully performed its first implantation of the Mitralign Percutaneous Annuloplasty System for mitral valve repair at French Hospital in Asuncion, Paraguay.
The patient was treated by an experienced medical team led by Adrian Ebner, M.D., of the French Hospital and Lutz Buellesfeld, M.D. of Helios Heart Center, Siegburg, Germany. The Mitralign System was able to remodel the valve and reduce the patient's mitral regurgitation from 3 to 2 , 24 hours after the procedure based on core lab assessment. The patient spent less than 48 hours in the hospital after the procedure and continues to do well at home.
The Mitralign System emulates the open surgical procedure of suture-based mitral annuloplasty. The implant was percutaneously delivered though a single 14F femoral arterial sheath, and provides direct geometric reduction of the posterior annulus.
"I have been involved with a number of mitral valve repair approaches; this approach is most exciting because it delivers on its promise to affect the valve on demand," Dr. Ebner said.
The case will be presented at two conference this month, including at the Cardiovascular Revascularization Therapies in Washington D.C. and the Joint Interventional Meeting in Rome.
For more information: www.mitralign.com